ATE370727T1 - Pharmazeutische suspensionstabletten- zusammenstellungen - Google Patents

Pharmazeutische suspensionstabletten- zusammenstellungen

Info

Publication number
ATE370727T1
ATE370727T1 AT98959527T AT98959527T ATE370727T1 AT E370727 T1 ATE370727 T1 AT E370727T1 AT 98959527 T AT98959527 T AT 98959527T AT 98959527 T AT98959527 T AT 98959527T AT E370727 T1 ATE370727 T1 AT E370727T1
Authority
AT
Austria
Prior art keywords
percent
tablets
microcrystalline cellulose
tablet compositions
pharmaceutical suspension
Prior art date
Application number
AT98959527T
Other languages
English (en)
Inventor
Michael Augello
Sheila Dell
George Agyilirah
George Reier
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fmc Corp filed Critical Fmc Corp
Application granted granted Critical
Publication of ATE370727T1 publication Critical patent/ATE370727T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
AT98959527T 1997-12-12 1998-11-20 Pharmazeutische suspensionstabletten- zusammenstellungen ATE370727T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/989,787 US5955107A (en) 1997-12-12 1997-12-12 Pharmaceutical suspension tablet compositions

Publications (1)

Publication Number Publication Date
ATE370727T1 true ATE370727T1 (de) 2007-09-15

Family

ID=25535456

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98959527T ATE370727T1 (de) 1997-12-12 1998-11-20 Pharmazeutische suspensionstabletten- zusammenstellungen

Country Status (7)

Country Link
US (1) US5955107A (de)
EP (1) EP1035838B1 (de)
AT (1) ATE370727T1 (de)
AU (1) AU1531199A (de)
DE (1) DE69838300T2 (de)
ES (1) ES2293694T3 (de)
WO (1) WO1999030689A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
AU753241C (en) * 1998-06-11 2003-05-08 Pharmacia & Upjohn Company Tablet formation
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
AU2001261744A1 (en) * 2000-05-19 2001-12-03 Npd Llc Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
MXPA04007169A (es) * 2002-01-25 2004-10-29 Santarus Inc Suministro transmucosal de inhibidores de bomba de protones.
MXPA04007428A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
EA200500213A1 (ru) * 2002-07-16 2005-08-25 Рэнбакси Лабораториз Лимитед Диспергируемые таблетки для орального назначения
US20070014850A1 (en) * 2002-08-02 2007-01-18 Ramalingam Manikandan Process for the preparation of dispersible tablets of cephalexin
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US20040161459A1 (en) * 2002-12-31 2004-08-19 Ngoc Do Fast-dissolve tablet technology
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7838029B1 (en) * 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
US7390503B1 (en) 2003-08-22 2008-06-24 Barr Laboratories, Inc. Ondansetron orally disintegrating tablets
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
EP1991241A4 (de) * 2006-02-23 2009-07-08 Iomedix Sleep Internat Srl Zusammensetzungen und verfahren zur einleitung und aufrechterhaltung von hochwertigem schlaf
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
US8901113B2 (en) 2009-09-30 2014-12-02 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse
ES2691982T3 (es) 2012-11-30 2018-11-29 Acura Pharmaceuticals, Inc. Liberación autorregulada de un principio activo farmacéutico
US9993497B2 (en) * 2012-12-30 2018-06-12 Hadasit Medical Research Services And Development Ltd. Use of alginate compositions in preventing or reducing liver damage caused by a hepatotoxic agent
US9616029B2 (en) 2014-03-26 2017-04-11 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
CA3239786A1 (en) * 2021-12-03 2023-06-08 Kapish KARAN An organic chewable composition comprising certified organic ingredients, and process for preparing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987005804A1 (en) * 1986-04-01 1987-10-08 The Upjohn Company Methylprednisolone/sodium carboxymethyl starch tablet composition
US5073377A (en) * 1988-11-03 1991-12-17 Miles Inc. Method of preparing oral dosage forms with a granulating composition
US4965072A (en) * 1988-11-03 1990-10-23 Miles Inc. Granulating composition and method
AU653203B2 (en) * 1991-01-30 1994-09-22 Wellcome Foundation Limited, The Water-dispersible tablets
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CA2205442C (en) * 1994-12-01 2003-01-21 David R. Friend Nsaid delivery employing a powdered hydrocolloid gum obtainable from higher plants
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
US5858409A (en) * 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals

Also Published As

Publication number Publication date
ES2293694T3 (es) 2008-03-16
EP1035838A1 (de) 2000-09-20
DE69838300D1 (de) 2007-10-04
WO1999030689A1 (en) 1999-06-24
EP1035838B1 (de) 2007-08-22
DE69838300T2 (de) 2008-05-15
EP1035838A4 (de) 2006-01-18
AU1531199A (en) 1999-07-05
US5955107A (en) 1999-09-21

Similar Documents

Publication Publication Date Title
ATE370727T1 (de) Pharmazeutische suspensionstabletten- zusammenstellungen
ES2223669T3 (es) Forma oral de dosificacion "una vez al dia" de metoprolol.
EA200000246A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
ATE209898T1 (de) Feste arzneizubereitung
ATE215816T1 (de) Feste oral anzuwendende arzeneiform
NO20065390L (no) Farmasoytisk preparat i fast enhetsdoseringsform
HUP0004383A2 (hu) Hatóanyagként klodronátot és vivőanyagként szilíciumozott mikrokristályos cellulózt tartalmazó gyógyszerészeti készítmény
MY129234A (en) Oral pharmaceutical forms of administration with a delayed action with tramadol.
DE69940557D1 (de) Ein hydrokolloid und einen celluloseether enthaltende tablette mit verzögerter freisetzung
NZ507566A (en) Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
EA200000245A1 (ru) Быстро дезинтегрирующие таблетки метилцеллюлозы
DE60120648D1 (de) Formulierungen von copolymer 1 (glatirameracetat) zur oralen, nasalen und pulmonalen verabreichung
MY104010A (en) Pharmaceutical compositions.
CA2330480A1 (en) Controlled release formulation of divalproex sodium
RU96116411A (ru) Быстро распадающаяся готовая препаративная форма трамадола или соли трамадола
DE60038536D1 (de) Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
CA2229283A1 (en) Prednisolone metasulphobenzoate preparation for the treatment of inflammatory bowel disease
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
BR0117147A (pt) preparado de dosagem oral de desintegração instantánea
HUP9801241A2 (hu) Vastagbélbe beadható, azathioprine tartalmú készítmények és eljárás előállításukra
NO962752L (no) Anvendelse av 2,3-diaryl-1-benzopyranderivater ved fremstilling av et medikament for behandling og forebyggelse av benvevstap og osteoporose
SE8901003D0 (sv) Snabbloesliga preparat
EA200401418A1 (ru) Способ получения таблеток из фармацевтически активных веществ, имеющих неблагоприятные свойства для таблетирования, с использованием гранулирующей жидкости, содержащей микрокристаллическую целлюлозу
YU47044B (sh) Postupak za dobijanje tableta sa produženim delovanjem na bazi hidroksipropil-metilceluloze velike molekularne mase

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties